Envista Holdings Corporation Common stock, $0.01 par value per share NVST
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIESi
Market dataready · fetched 2026-11-11T15:51:30.935Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:51:23.812648766Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T15:51:27.594610+00:00
Envista Holdings Corporation Common stock, $0.01 par value per share options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 29.92 | 52.4% | 19.2% | 22.69 | 48.1% | 12.8% |
| 25Δ | 29.31 | 50.3% | 17.3% | 23.25 | 46.4% | 11.1% |
| 30Δ | 28.69 | 48.2% | 15.4% | 23.81 | 44.7% | 9.5% |
| 35Δ | 28.08 | 46.2% | 13.5% | 24.37 | 43.0% | 7.8% |
| 40Δ | 27.46 | 44.1% | 11.6% | 24.93 | 41.3% | 6.2% |
| 45Δ | 26.85 | 42.0% | 9.6% | |||
| 50Δ | 26.23 | 40.0% | 7.7% | |||
| 55Δ | 25.62 | 37.9% | 5.8% | |||
| 60Δ | 25.00 | 35.8% | 3.9% | |||
| 65Δ | 24.05 | 44.2% | 3.6% | |||
| 70Δ | 23.10 | 52.6% | 3.3% | |||
| 75Δ | 22.15 | 60.9% | 3.0% | |||
| 80Δ | 21.20 | 69.3% | 2.7% | |||
20Δ
- Pseudo strike
- 29.92
- IV
- 52.4%
- B/E move
- 19.2%
- Pseudo strike
- 22.69
- IV
- 48.1%
- B/E move
- 12.8%
25Δ
- Pseudo strike
- 29.31
- IV
- 50.3%
- B/E move
- 17.3%
- Pseudo strike
- 23.25
- IV
- 46.4%
- B/E move
- 11.1%
30Δ
- Pseudo strike
- 28.69
- IV
- 48.2%
- B/E move
- 15.4%
- Pseudo strike
- 23.81
- IV
- 44.7%
- B/E move
- 9.5%
35Δ
- Pseudo strike
- 28.08
- IV
- 46.2%
- B/E move
- 13.5%
- Pseudo strike
- 24.37
- IV
- 43.0%
- B/E move
- 7.8%
40Δ
- Pseudo strike
- 27.46
- IV
- 44.1%
- B/E move
- 11.6%
- Pseudo strike
- 24.93
- IV
- 41.3%
- B/E move
- 6.2%
45Δ
- Pseudo strike
- 26.85
- IV
- 42.0%
- B/E move
- 9.6%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 26.23
- IV
- 40.0%
- B/E move
- 7.7%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 25.62
- IV
- 37.9%
- B/E move
- 5.8%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 25.00
- IV
- 35.8%
- B/E move
- 3.9%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 24.05
- IV
- 44.2%
- B/E move
- 3.6%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 23.10
- IV
- 52.6%
- B/E move
- 3.3%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 22.15
- IV
- 60.9%
- B/E move
- 3.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 21.20
- IV
- 69.3%
- B/E move
- 2.7%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 49.79% | |
| 44.25% | |
| 43.99% | |
| 45.74% | |
| 45.43% | |
| 48.30% | |
| 48.26% | |
| 46.23% | |
| 43.40% | |
| 41.80% |
Medical Instruments & Supplies
OSUR
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and…
More →PLSE
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
More →RGEN
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and…
More →RMD
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices…
More →SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.…
More →STAA
STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company…
More →